| Date: |
14-06-2021
|
| Notification No: |
Notification No. 08/2015-2020
|
| Issuing Authority: |
DGFT
|
| Type: |
Notification
|
| File No: |
F.No.01/91/180/24/AM22/EC/E-27724 |
| Subject: |
Amendment in Export Policy of Injection Remdesivir and Remdesivir API.
|
|
Government of India
Ministry of Commerce &
Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi
Notification No. 08/2015-2020
Dated: 14th June, 2021
Subject: Amendment in Export Policy of Injection
Remdesivir and Remdesivir API.
S.O. 2332(E) In exercise of powers
conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992
(No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade
Policy, 2015-20, the Central Government hereby amends the Notification No.
01/2015-20 dated 11.04.2021 related to export of Injection Remdesivir and
Remdesivir Active Pharmaceutical Ingredients (API):
| S.No |
ITC HS Codes |
Description |
Present Policy |
Revised Policy |
| 207AA |
Ex 293499 Ex 300490 |
Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients(API) |
Prohibited |
Restricted |
2. The export of Remdesivir Injections/API
against the Advance Authorizations issued under Chapter 4 of FTP/HBP shall not
require a separate export authorisation or permission.
3. Effect of this
Notification:
The export of Injection Remdesivir and Remdesivir Active
Pharmaceutical Ingredients (API) falling under the ITC (HS) Codes specified
above or falling under any other HS Code has been put under Restricted category
with immediate effect. The export of Remdesivir injections/API against the
Advance Authorizations will not require a separate authorisation/ permission.
(Issued from F.No.01/91/180/24/AM22/EC/E-27724)
(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional
Secretary, GoI
Email- dgft(ar) iic.in
|
|
|